Skip to main navigation Skip to search Skip to main content

Mechanism and adverse effects of COVID-19 drugs: a basic review

  • Nadia Mohammad Zadeh
  • , Nazli Sadat Mashinchi Asl
  • , Khatereh Forouharnejad
  • , Keyvan Ghadimi
  • , Sara Parsa
  • , Sima Mohammadi
  • , Ashkan Omidi

Research output: Contribution to journalReview articlepeer-review

Abstract

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Coronavirus disease 2019 (COVID-19) is chronic, inflammatory. Although the exact mechanisms of COVID-19 have not been yet discovered some drugs are found helpful for its treatment. These drugs which are divided into some lines therapies, have demonstrated to be helpful for COVID-19 patients based on immune basic and its antiviral properties of the disease. Previous studies have been indicated that deterioration of COVID-19 condition is associated with a weaker immune system. Most of these therapies impact on the immune system and immune cells. Beside many beneficial effects of these drugs, some adverse effects (AE) have been reported in many experiments and clinical trials among patients suffering from COVID-19. In this review, we conclude some AEs of vitamin-D, zinc, remdesivir, hydroxychloroquine or chloroquine, azithromycin, dexamethasone, amantadine, aspirin reported in different papers and we continue the rest of the drugs in second part of our review article.

Original languageEnglish
Pages (from-to)102-109
Number of pages8
JournalInternational journal of physiology, pathophysiology and pharmacology
Volume13
Issue number4
Publication statusPublished - 2021
Externally publishedYes

Fingerprint

Dive into the research topics of 'Mechanism and adverse effects of COVID-19 drugs: a basic review'. Together they form a unique fingerprint.

Cite this